Sign In
Buy SLNO
$53.01
+0 (+0%)
At Close: Jun 23, 2026
SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Soleno Therapeutics, Inc. (NASDAQ: SLNO) common stock between March 26, 2025 and November 4,
Soleno Therapeutics, Inc. (SLNO) Q4 2025 Earnings Call Transcript
04:27am, Thursday, 26'th Feb 2026
Soleno Therapeutics, Inc. (SLNO) Q4 2025 Earnings Call Transcript
Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
04:01pm, Wednesday, 25'th Feb 2026
REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases,
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
10:36am, Monday, 02'nd Feb 2026
The heavy selling pressure might have exhausted for Soleno Therapeutics (SLNO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street
Analyzing Soleno Therapeutics (NASDAQ:SLNO) & Xeris Biopharma (NASDAQ:XERS)
01:28am, Thursday, 29'th Jan 2026
Xeris Biopharma (NASDAQ: XERS - Get Free Report) and Soleno Therapeutics (NASDAQ: SLNO - Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses
Emerald Advisers LLC Trims Position in Soleno Therapeutics, Inc. $SLNO
04:49am, Thursday, 22'nd Jan 2026
Emerald Advisers LLC lessened its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) by 6.7% in the third quarter, according to the company in its most recent disclosure with the Securitie
14,786 Shares in Soleno Therapeutics, Inc. $SLNO Bought by SG Americas Securities LLC
05:26am, Monday, 19'th Jan 2026
SG Americas Securities LLC acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the third quarter, according to its most recent disclosure with the Securities and Excha
SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation
08:00pm, Friday, 16'th Jan 2026
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:
Soleno Therapeutics (SLNO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
10:55am, Wednesday, 14'th Jan 2026
After losing some value lately, a hammer chart pattern has been formed for Soleno Therapeutics (SLNO), indicating that the stock has found support. This, combined with an upward trend in earnings esti
New Strong Buy Stocks for January 13th
05:30am, Tuesday, 13'th Jan 2026
KNOP, OESX, LAND, FET and SLNO have been added to the Zacks Rank #1 (Strong Buy) List on Jan.13, 2026.
SLNO Investors: Contact Kirby McInerney LLP About Investigation into Soleno Therapeutics, Inc.
06:00pm, Monday, 12'th Jan 2026
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:SLNO) investors concerning
Soleno Therapeutics (NASDAQ:SLNO) Stock Price Down 4.2% – Here’s What Happened
04:46am, Sunday, 11'th Jan 2026
Shares of Soleno Therapeutics, Inc. (NASDAQ: SLNO - Get Free Report) were down 4.2% during mid-day trading on Friday. The company traded as low as $43.40 and last traded at $43.5910. Approximately 525
SLNO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
06:00pm, Friday, 09'th Jan 2026
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
10:00am, Thursday, 08'th Jan 2026
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advis
5 Small Drug Stocks to Buy as Industry Recovery Picks Up
09:46am, Wednesday, 07'th Jan 2026
Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions to one's portfolio.
